[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"H.C. Wainwrightthe PT on $LXEO to $XX from $X plusLX2006's odds of approval to XX% from XX% and movedthe expected launch to 2028 from 2030 after the Co📰that the FDA has indicated openness to a BLA submission for accelerated approval (AA); reiterated Buy. $LRMR $BIIB"
X Link @Quantumup1 2025-10-07T15:29Z 3826 followers, 2518 engagements
"H.C. Wainwright $LXEO's PT to $X from $XX (Dilution Related - Modified OP Expenses) reit'd at Buy and says that it views 'LX2020 is nearing its 2H25 interim readout in a risk-mitigated position.' $RCKT $TNYA $LRMR $PTCT $BIIB H.C. Wainwright said in its note: Lexeo disclosed that eight patients have now been dosed in the Phase 1/2 (HEROIC-PKP2) trial of LX2020 spanning three cohorts-low dose (n=3) high dose (n=3) and high-dose expansion (n=2)-with interim data expected in 2H25. We believe LX2020 is positioned well in lieu of competitor data from Rocket Pharmaceuticals' ( $RCKT; not rated)"
X Link @Quantumup1 2025-08-15T15:05Z 3826 followers, 4235 engagements